Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

FGF23 regulates renal sodium handling and blood pressure
Olena Andrukhova, Svetlana Slavić, Alina Smorodchenko, et al.
EMBO Molecular Medicine (2014) Vol. 6, Iss. 6, pp. 744-759
Open Access | Times Cited: 298

Showing 1-25 of 298 citing articles:

FGF/FGFR signaling in health and disease
Yangli Xie, Nan Su, Jing Yang, et al.
Signal Transduction and Targeted Therapy (2020) Vol. 5, Iss. 1
Open Access | Times Cited: 594
The Klotho proteins in health and disease
Makoto Kuro‐o
Nature Reviews Nephrology (2018) Vol. 15, Iss. 1, pp. 27-44
Closed Access | Times Cited: 558
Vascular calcification in CKD-MBD: Roles for phosphate, FGF23, and Klotho
Shunsuke Yamada, Cecilia M. Giachelli
Bone (2016) Vol. 100, pp. 87-93
Open Access | Times Cited: 271
FGF23 and its role in X-linked hypophosphatemia-related morbidity
Signe Sparre Beck‐Nielsen, Zulf Mughal, Dieter Haffner, et al.
Orphanet Journal of Rare Diseases (2019) Vol. 14, Iss. 1
Open Access | Times Cited: 220
Secondary Osteoporosis
Peter R. Ebeling, Hanh H. Nguyen, Jasna Aleksova, et al.
Endocrine Reviews (2021) Vol. 43, Iss. 2, pp. 240-313
Open Access | Times Cited: 190
The chronic kidney disease — Mineral bone disorder (CKD-MBD): Advances in pathophysiology
Keith A. Hruska, Toshifumi Sugatani, Olga A. Agapova, et al.
Bone (2017) Vol. 100, pp. 80-86
Open Access | Times Cited: 180
The role of klotho in chronic kidney disease
Di Zou, Wen Wu, Yan He, et al.
BMC Nephrology (2018) Vol. 19, Iss. 1
Open Access | Times Cited: 177
FGF23 Actions on Target Tissues—With and Without Klotho
Beatrice Richter, Christian Faul
Frontiers in Endocrinology (2018) Vol. 9
Open Access | Times Cited: 175
Interdisciplinary management of FGF23-related phosphate wasting syndromes: a Consensus Statement on the evaluation, diagnosis and care of patients with X-linked hypophosphataemia
Andrea Trombetti, Nasser M. Al‐Daghri, Maria Luisa Brandi, et al.
Nature Reviews Endocrinology (2022) Vol. 18, Iss. 6, pp. 366-384
Open Access | Times Cited: 79
FGF23 and klotho at the intersection of kidney and cardiovascular disease
Daniel Edmonston, Alexander Grabner, Myles Wolf
Nature Reviews Cardiology (2023) Vol. 21, Iss. 1, pp. 11-24
Closed Access | Times Cited: 55
Regulation of FGF23 production and phosphate metabolism by bone–kidney interactions
Rafiou Agoro, Kenneth E. White
Nature Reviews Nephrology (2023) Vol. 19, Iss. 3, pp. 185-193
Closed Access | Times Cited: 44
FGF-based drug discovery: advances and challenges
Gaozhi Chen, Lingfeng Chen, Xiaokun Li, et al.
Nature Reviews Drug Discovery (2025)
Closed Access | Times Cited: 4
FGF23 Regulates Bone Mineralization in a 1,25(OH)2D3 and Klotho-Independent Manner
Sathish K. Murali, Paul Roschger, Ute Zeitz, et al.
Journal of Bone and Mineral Research (2015) Vol. 31, Iss. 1, pp. 129-142
Open Access | Times Cited: 155
FGF23-Klotho signaling axis in the kidney
Reinhold G. Erben, Olena Andrukhova
Bone (2016) Vol. 100, pp. 62-68
Open Access | Times Cited: 151
Renal and extrarenal effects of fibroblast growth factor 23
Marc G. Vervloet
Nature Reviews Nephrology (2018) Vol. 15, Iss. 2, pp. 109-120
Closed Access | Times Cited: 142
Physiological Actions of Fibroblast Growth Factor-23
Reinhold G. Erben
Frontiers in Endocrinology (2018) Vol. 9
Open Access | Times Cited: 127
The FGF metabolic axis
Xiaokun Li
Frontiers of Medicine (2019) Vol. 13, Iss. 5, pp. 511-530
Open Access | Times Cited: 120
Phosphate—a poison for humans?
Hirotaka Komaba, Masafumi Fukagawa
Kidney International (2016) Vol. 90, Iss. 4, pp. 753-763
Open Access | Times Cited: 118
Counter-regulatory paracrine actions of FGF-23 and 1,25(OH)2D in macrophages
Xiaobin Han, Linqiang Li, Jiancheng Yang, et al.
FEBS Letters (2015) Vol. 590, Iss. 1, pp. 53-67
Open Access | Times Cited: 115
Cardiac Remodeling in Chronic Kidney Disease
Nadine Kaesler, Anne Babler, Jürgen Floege, et al.
Toxins (2020) Vol. 12, Iss. 3, pp. 161-161
Open Access | Times Cited: 115
Update on FGF23 and Klotho signaling
Reinhold G. Erben
Molecular and Cellular Endocrinology (2016) Vol. 432, pp. 56-65
Open Access | Times Cited: 114
Excessive Osteocytic Fgf23 Secretion Contributes to Pyrophosphate Accumulation and Mineralization Defect in Hyp Mice
Sathish K. Murali, Olena Andrukhova, Erica L. Clinkenbeard, et al.
PLoS Biology (2016) Vol. 14, Iss. 4, pp. e1002427-e1002427
Open Access | Times Cited: 113
Inhibition of fibroblast growth factor 23 (FGF23) signaling rescues renal anemia
Rafiou Agoro, Anna Montagna, Regina Goetz, et al.
The FASEB Journal (2018) Vol. 32, Iss. 7, pp. 3752-3764
Open Access | Times Cited: 101
The role of the anti-ageing protein Klotho in vascular physiology and pathophysiology
Rik Mencke, Jan‐Luuk Hillebrands
Ageing Research Reviews (2016) Vol. 35, pp. 124-146
Closed Access | Times Cited: 96
Bone function, dysfunction and its role in diseases including critical illness
Nan Su, Jing Yang, Yangli Xie, et al.
International Journal of Biological Sciences (2019) Vol. 15, Iss. 4, pp. 776-787
Open Access | Times Cited: 91
Page 1 - Next Page

Scroll to top